Accelerating innovation underpinned by strong secular growth drivers is creating an increasing opportunity to invest in innovative and differentiated healthcare products and services that can help address a growing need for better, more efficient, and accessible healthcare. Against this backdrop, EQT has established a dedicated healthcare mid-market buyout strategy: EQT Healthcare Growth to predominantly make control investments in innovative, profitable companies with a strong growth outlook.

By applying EQT’s active ownership approach and leveraging its global network, EQT Healthcare Growth seeks to scale companies in the same subsectors as EQT Private Equity by building commercial muscle and expanding their global reach to generate attractive risk-adjusted returns and simultaneously deliver positive outcomes across the healthcare value chain.

The dedicated EQT Healthcare Growth team is supported by an active Investment Committee including relevant senior EQT leaders and is an integral part of EQT’s global healthcare sector vertical and the broader Private Capital platform. The team combines the deep scientific expertise and ability to identify emerging trends from EQT Life Sciences with EQT Private Equity’s value creation playbook and 30-year track record in healthcare investing.